Compare ImmunityBio Inc. Common Stock (IBRX) vs SentinelOne Inc. Class A Common Stock (S) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs SentinelOne Inc. Class A Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.47 (market cap $10.51B), while SentinelOne Inc. Class A Common Stock trades at $26.35 (market cap $8.84B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and SentinelOne Inc. Class A Common Stock is trading nearer its 52-week high, ImmunityBio Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and SentinelOne Inc. Class A Common Stock for 1 Days on average.
| IBRX | S | |
|---|---|---|
Market Cap | $10.51B | $8.84B |
Volume | 10,445,785 | 7,515,091 |
Sector | Health | Technology |
52-Week High | $11.55 | $25.80 |
52-Week Low | $1.98 | $11.94 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $8.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About SentinelOne Inc. Class A Common Stock
SentinelOne provides an AI-powered cybersecurity platform for organizations. Its Singularity platform helps detect, prevent, and respond to threats across endpoints, cloud workloads, identities, and connected devices.
Read more on S →
